Jianli Guan

Jianli Guan

Auto-generated profile, based on publicly available information

Jianli Guan

Henan Fusen Pharmaceutical Co., Ltd., Henan, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JXJia-Qi Xu
Jia-Qi Xu
SSShi-Bing Su
Shi-Bing Su
CCC. Y. Chen
C. Y. Chen
JGJ. Gao
J. Gao
ZCZ. M. Cao
Z. M. Cao
YHYuanjia Hu
Yuanjia Hu
The hepatitis B virus (HBV) is one of the major viral infection problems worldwide in public health. The exclusive proprietary Chinese medicine Ganweikang (GWK) tablet has been marketed for years in the treatment of chronic hepatitis B (CHB). However, the pharmacodynamic material basis and underlying mechanism of GWK are not completely clear. This study is aimed at investigating the pharmacological mechanism of the GWK tablet in the treatment of CHB. The chemical ingredient information was obtained from the Traditional Chinese Medicine Database and Analysis Platform (TCMSP), Traditional Chinese Medicines Integrated Database (TCMID), and Shanghai Institute of Organic Chemistry of CAS. Ingredients and disease‐related targets were defined by a combination of differentially expressed genes from CHB transcriptome data and open‐source databases. Target‐pathway‐target (TPT) network analysis, molecular docking, and chemical composition analysis were adopted to further verify the key targets and corresponding active ingredients of GWK. Eight herbs of GWK were correlated to 330 compounds with positive oral bioavailability, and 199 correlated targets were identified. The TPT network was constructed based on the 146 enriched targets by KEGG pathway analysis, significantly associated with 95 pathways. Twenty‐five nonvolatile components and 25 volatile components in GWK were identified in UPLC‐QTOF/MS and GC‐MS chromatograms. The key active ingredients of GWK include ferulic acid, oleanolic acid, ursolic acid, tormentic acid, 11‐deoxyglycyrrhetic acid, dibenzoyl methane, anisaldehyde, wogonin, protocatechuic acid, psoralen, caffeate, dimethylcaffeic acid, vanillin, β‐amyrenyl acetate, formonentin, aristololactam IIIa, and 7‐methoxy‐2‐methyl isoflavone, associated with targets CA2, NFKB1, RELA, AKT1, JUN, CA1, CA6, IKBKG, FOS, EP300, CREB1, STAT1, MMP9, CDK2, ABCB1, and ABCG2.

19 September 2022 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
YWYang Wang
Yang Wang
ZYZhaorui Yin
Zhaorui Yin
KZKai Zhang
Kai Zhang
QMQingfen Meng
Qingfen Meng
JGJianli Guan
Jianli Guan
GFGuanwei Fan
Guanwei Fan
This study has developed a sensitive, simple, and reliable ultrahigh performance liquid chromatography tandem mass spectrometry method for the simultaneous determination of corydaline, tetrahydropalmatine, tetrahydroberberine, tetrahydrocoptisine, byakangelicin, and byakangelicol in beagle dog plasma after oral administration of Yuanhu Zhitong (YHZT) oral liquid, dispersible tablet, and dropping pills. A one-step protein precipitation method was used with methanol-acetonitrile (50:50, v/v) for plasma sample pretreatment. Six analytes and one internal standard were separated on a Waters Acquity UPLC BEH C18 column (2.1mm×100mm, 1.7μm) by gradient elution with 0.1 formic acid-water and 0.1 formic acid-acetonitrile at a flow rate of 0.4mL/min. Detection was conducted by multiple reaction monitoring mode in the positive ionization. The calibration curves showed good linearity (r>0.9920). The lower limit of quantization ranged from 0.1 to 1ng/mL. Moreover, the other results of the method validation were within the acceptable range. After oral administration, the pharmacokinetic characteristics of the three YHZT preparations were different. Compared with the two solid preparations, the absorption of the six analytes in oral liquid was more rapid. Moreover, the area under the plasma drug concentration-time curve and the maximum plasma concentration of tetrahydropalmatine (the main analgesic component of YHZT prescription) in the oral liquid group were higher than those in the other two groups. The results showed oral liquid can exert its efficacy quickly, while dispersible tablet and dropping pills exhibit relatively slow release pattern. The comparative pharmacokinetic study would be helpful to the clinical rational selection and application of YHZT preparations.